Press Release
Category Added in a WPeMatico Campaign
-
COLERIDGE’S 6TH ANNUAL NATIONAL CONFERENCE CENTERS ON THE IMPORTANCE OF COLLABORATION ACROSS BORDERS
Building Connections to Bridge Divides and Accelerate Decision Making WASHINGTON, March 31, 2026 /PRNewswire/ — Coleridge hosted its 6th Annual…
Read More » -
Katten Advises Marc Zahr and the Chaifetz Group in Acquisition of Portland Trail Blazers
CHICAGO, March 31, 2026 /PRNewswire/ — Katten announced today that it represented Marc Zahr and the Chaifetz Group, significant investors…
Read More » -
Duke Energy completes sale of its Tennessee Piedmont Natural Gas business to Spire
Close of transaction previously announced in July 2025 Proceeds to help fund industry’s largest regulated capital plan CHARLOTTE, N.C., March…
Read More » -
SiriusXM to Report First Quarter 2026 Operating and Financial Results
NEW YORK, March 31, 2026 /PRNewswire/ — SiriusXM (NASDAQ: SIRI) will release its first quarter 2026 operating and financial results…
Read More » -
Bit Digital, Inc. Announces Fiscal Year 2025 Financial Results
NEW YORK, March 31, 2026 /PRNewswire/ — Bit Digital, Inc. (Nasdaq: BTBT) (the “Company”), today announced its financial results for…
Read More » -
Spire completes acquisition of Tennessee Piedmont Natural Gas business from Duke Energy
Expands regulated utility footprint with Spire Tennessee becoming the largest investor-owned natural gas utility in Tennessee Committed to providing a…
Read More » -
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
TEL AVIV, Israel, March 31, 2026 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical…
Read More » -
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
TEL AVIV, Israel, March 31, 2026 /PRNewswire/ — Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical…
Read More »
